Doc In AstraZeneca Bribe Scandal Commits Suicide
A key figure in a scandal in which AstraZeneca was indicted in Serbia over allegations of offering bribes to physicians has committed suicide. Nenad Borojevic, who was the former director of the Serbian Institute of Oncology and Radiology Nenad Borojevic, was found hanging from a tree in a forest in Belgrade, according to media reports […]
Read More »Category : News
J&J Warned By FDA Over Remarks By Sales Rep
You know the old adage to be careful about what you say? This is a golden rule that sales reps should remember, especially when participating in discussions at industry gatherings. We say this because the FDA has just released a letter to a Johnson & Johnson unit over remarks made by an employee, who was […]
Read More »Category : News
CEOs Blame FDA For Slow Growth
As they say, money isn’t everything. And while CEOs at some biotechs as well as small drug and device makers, lament the lack of funding for their projects, an overwhelming majority also blame the FDA for slowing the growth of their companies. At least that is what a new survey of approximately 100 such companies […]
Read More »Category : News
Oh, Canada… Pharma Is Taking Some Jobs Away
We all know that emerging markets in Asia, for instance, are hot, especially when it comes to opening new manufacturing plants and research facilities. But Canada is not among them. So it may not come as a surprise that two of the largest drugmakers are shrinking their ranks there. Over the last 36 hours, both […]
Read More »Category : News
FDA Warns Against Using Over the Counter Novartis Drugs
It has been recently said by the US Food and Drug Administration (FDA) authorities that drugs like Percocet, which are addictive in nature, may now be included in the new drug mix up plan by Novartis. They are of the warning that this might be the potential reason for a terrible drug mix up. In […]
Read More »Category : News
Federal regulators warn Johnson & Johnson’s insulin pump business to correct violations
Federal drug regulators have chastised Johnson & Johnson’s subsidiary, Animas, for selling faulty insulin pumps and failing to report injuries suffered by patients using its devices. In a warning letter to Animas managment, regulators with the Food and Drug Administration described numerous instances when the company failed to comply with regulations requiring it to report […]
Read More »Category : News
FDA probing J&J delays in reporting serious injuries among users of its Animas insulin pump
The widening quality problems at health giant Johnson & Johnson have former regulators and analysts mystified, as yet another J&J business — at least the seventh — has come under scrutiny. The lapses are hard to reconcile with J&J’s image: It’s the company that decades ago set the textbook standard for protecting public safety with […]
Read More »Category : News
FDA warns of pain pill mix-ups
The Food and Drug Administration is warning patients about a potential mix-up between powerful prescription pain drugs and common over-the-counter medications made at a Novartis manufacturing plant. The issue stems from manufacturing problems at a Lincoln, Neb., facility which triggered a recall Sunday of 1,645 lots of Novartis’ over-the-counter drugs, including Excedrin, Bufferin, NoDoz and […]
Read More »Category : News
Myth Versus Reality: Promoting A Pricey Gout Pill
Nearly three years ago, the FDA approved a version of colchicine – a cheap, decades-old treatment for gout – and a controversy quickly ensued. The new med won approval under the Orphan Drug Act, which means the manufacturer received seven years of marketing exclusivity. And the FDA later forced other manufacturers to halt marketing on […]
Read More »Category : News
Americans Cut Back on Health Care During Recession
In 2009 and 2010 total health care spending grew at just under 4 percent, at the slowest rate since the government began keeping records over fifty years ago, one big reason is that Americans dramatically curtailed their use of physician and hospital services. “This certainly was a very deep and significant recession,†said Stephen Heffler, […]
Read More »Category : News
